Companies › BLFS
BIOLIFE SOLUTIONS INC COM NEW (BLFS)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0000834365 · EDGAR filings · Updated 2026-07-24
BIOLIFE SOLUTIONS INC COM NEW (BLFS) has reported institutional ownership of 102.0%, with 187 institutional managers holding positions valued at $951.3M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (3)
- 2026-07-24 — 425 filed
- 2026-07-22 — Current report (8-K) filed
- 2026-07-22 — 425 filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-21 — Insider transaction reported (Form 4)
- 2026-07-13 — Insider transaction reported (Form 4)
- 2026-07-13 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, BIOLIFE SOLUTIONS INC COM NEW has 187 institutional holders and institutional ownership of 102.0%.
Insider activity
Insiders reported 126 transactions (0 buys, 92 sells) across 16 reporting insiders, with a net reported value of −$77.8M.
Data flags from SEC filings
Related companies
CADRE HLDGS INC (CDRE) · ARRIVENT BIOPHARMA INC (AVBP) · NOVAVAX INC (NVAX) · FRESENIUS MEDICAL CARE AG (FMS) · PENNANT GROUP INC (PNTG) · NUVATION BIO INC (NUVB)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-24.